Priovant Takes Brepocitinib Ahead After CS Success

 
• By Alaric DeArment
  
Blue figurine
Priovant announced positive results for brepocitinib in the rare disease cutaneous sarcoidosis. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business